Article
Experimental evolution to identify undescribed mechanisms of resistance to a novel cationic peptide antibiotic
2020-12-16
Abstract excerpt
A key strategy for resolving the antibiotic resistance crisis is the development of new drugs with antimicrobial properties. The engineered cationic antimicrobial peptide WLBU2 (also known as PLG0206) is a promising broad-spectrum antimicrobial compound that has completed Phase I clinical studies. It has activity against Gram-negative and Gram-positive bacteria including infections associated with biofilm. No defi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1694dd56-868a-56d5-a56c-89c1c123ecf1
- DOI
- 10.1101/2020.12.16.423161
